NuCana (NCNA) Cash from Financing Activities (2017 - 2025)

NuCana's (NCNA) quarterly Cash from Financing Activities came in at $9311.2 in Q4 2025, down 99.67% year-on-year from $2.8 million in Q4 2024, and down 99.95% quarter-over-quarter from $20.6 million in Q3 2025.

NuCana (NCNA) Cash from Financing Activities (2017 - 2025) Analysis & Trends

NuCana has disclosed Cash from Financing Activities across 9 years of filings, most recently posting $9311.2 for Q4 2025.

  • Cash from Financing Activities for Q4 2025 came in at $9311.2, down 99.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $29.5 million (up 178.93% YoY), and the FY2025 annual result was $33.0 million, up 215.16% from the prior year.
  • Cash from Financing Activities came in at $9311.2 for Q4 2025 at NuCana, down from $20.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $20.6 million in Q3 2025 to a low of -$103431.9 in Q2 2021.
  • The 5-year median for Cash from Financing Activities is -$44807.7 (2022), against an average of $1.7 million.
  • Across the five-year window, Cash from Financing Activities tumbled 268.52% in 2023 and soared 7394.38% in 2024, its largest moves.
  • NuCana's Cash from Financing Activities stood at -$99752.8 in 2021, then jumped by 131.75% to $31669.1 in 2022, then tumbled by 268.52% to -$53369.5 in 2023, then surged by 5354.78% to $2.8 million in 2024, then sank by 99.67% to $9311.2 in 2025.
  • The last three Cash from Financing Activities figures came in at $9311.2 (Q4 2025), $20.6 million (Q3 2025), and $2.8 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 7.00 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 53,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -538.80 Mn
9 Abivax 94.26 Bn 94.26 Bn - 85,464.43
10 NuCana 29.13 Bn 29.13 Bn - 9,311.16

Historic Data

Download Data
DateValue
Dec 31, 2025 9,311.16
Dec 31, 2025 9,311.16
Sep 30, 2025 20.56 Mn
Sep 30, 2025 20.56 Mn
Dec 31, 2024 2.80 Mn
Dec 31, 2024 2.80 Mn
Sep 30, 2024 6.08 Mn
Sep 30, 2024 6.08 Mn
Jun 30, 2024 -79,519.91
Jun 30, 2024 -79,519.91
Mar 31, 2024 1.76 Mn
Mar 31, 2024 1.76 Mn
Dec 31, 2023 -53,369.53
Dec 31, 2023 -53,369.53
Sep 30, 2023 81,067.83
Sep 30, 2023 81,067.83
Jun 30, 2023 -41,294.98
Jun 30, 2023 -41,294.98
Mar 31, 2023 -49,835.89
Mar 31, 2023 -49,835.89